\-\ Texto\\:\\ \ \(0\)\
\-\ ct\\ is\\ ordered\\.\ \(0\)\
\-\ the\\ mass\\ was\\ excised\\ and\\ patient\\ recovered\\ without\\ recurrence\\.\ \(0\)\
\-\ fig\\.\\ 1\\ coronal\\ t1\\-weighted\\ mr\\ image\\ which\\ shows\\ the\\ well\\-defined\\,\\ fairly\\ homogeneous\\ mass\\ which\\ is\\ slightly\\ hypointense\\ to\\ the\\ adjacent\\ liver\\ \\(red\\ arrow\\)\\.\\ note\\ also\\ the\\ curvilinear\\ dark\\ structures\\ near\\ the\\ interface\\ between\\ the\\ mass\\ and\\ the\\ liver\\.\\ these\\ are\\ flow\\ voids\\ from\\ large\\ vessels\\ \\(yellow\\ arrows\\)\\.\ \(0\)\
\-\ fig\\.\\ 2\\:\\ this\\ coronal\\ t2\\-weighted\\ image\\ shows\\ the\\ well\\-circumscribed\\ mass\\ is\\ slightly\\ hyperintense\\ to\\ liver\\ and\\ the\\ central\\ scar\\ is\\ hyperintense\\ \\(yellow\\ arrows\\)\\,\\ whereas\\ the\\ scar\\ was\\ hypointense\\ on\\ the\\ t1\\-weighted\\ image\\.\ \(0\)\
\-\ fig\\.\\ 3\\:\\ a\\ sagittal\\ post\\ contrast\\ t1\\-weighted\\ image\\ was\\ obtained\\ in\\ the\\ delayed\\ phase\\.\\ the\\ mass\\ is\\ now\\ isointense\\ to\\ liver\\ \\(red\\ arrows\\)\\ but\\ the\\ scar\\ is\\ enhancing\\ \\(yellow\\ arrow\\)\\.\\ enhancement\\ on\\ delayed\\ mr\\ differentiates\\ the\\ fnh\\ from\\ fibrolamellar\\ carcinoma\\,\\ a\\ form\\ of\\ hcc\\.\ \(0\)\
\-\ fig\\.\\ 4\\ mass\\ is\\ resected\\.\\ note\\ the\\ well\\ demarcated\\ margin\\ surrounding\\ the\\ tumor\\ \\(red\\ arrows\\)\\,\\ and\\ the\\ fibrous\\ branching\\ scar\\ \\(yellow\\ arrows\\)\\.\\ the\\ parenchyma\\ is\\ a\\ tan\\ color\\,\\ lighter\\ than\\ the\\ adjacent\\ liver\\,\\ even\\ in\\ situ\\.\ \(0\)\
\-\ fnh\\ \\-\\ focal\\ nodular\\ hyperplasia\ \(0\)\
\-\ \\â\\€\\¢\\ focal\\ nodular\\ hyperplasia\ \(0\)\
\-\ \\â\\€\\¢\\ choliangiocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ hepatic\\ adenoma\ \(0\)\
\-\ \\â\\€\\¢\\ cavernous\\ hemangioma\ \(0\)\
\-\ \\â\\€\\¢\\ fibrolamellar\\ carcinoma\ \(0\)\
\-\ a\\ 6\\ year\\ old\\ girl\\ presents\\ with\\ diffuse\\ abdominal\\ pain\\.\ \(0\)\
\-\ \\[see\\ quiz\\ for\\ this\\ case\\]\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\	titelbaum\\,\\ d\\.s\\.\\,\\ et\\ al\\.\\,\\ fibrolamellar\\ hepatocellular\\ carcinoma\\:\\ pitfalls\\ in\\ nonoperative\\ diagnosis\\.\\ radiology\\,\\ 1988\\.\\ 167\\(1\\)\\:\\ p\\.\\ 25\\-30\\.\ \(0\)\
\-\ 2\\.\\	mclarney\\,\\ j\\.k\\.\\,\\ et\\ al\\.\\,\\ fibrolamellar\\ carcinoma\\ of\\ the\\ liver\\:\\ radiologic\\-pathologic\\ correlation\\.\\ radiographics\\,\\ 1999\\.\\ 19\\(2\\)\\:\\ p\\.\\ 453\\-71\\.\ \(0\)\
\-\ 3\\.\\	wheeler\\,\\ y\\.y\\.\\,\\ et\\ al\\.\\,\\ metastatic\\ renal\\ cell\\ carcinoma\\ within\\ a\\ hepatic\\ focal\\ nodular\\ hyperplasia\\:\\ a\\ case\\ report\\ and\\ review\\ of\\ the\\ literature\\.\\ int\\ j\\ clin\\ exp\\ pathol\\,\\ 2009\\.\\ 2\\(2\\)\\:\\ p\\.\\ 190\\-3\\.\ \(0\)\
\-\ 4\\.\\	demir\\,\\ h\\.a\\.\\,\\ et\\ al\\.\\,\\ focal\\ nodular\\ hyperplasia\\ of\\ the\\ liver\\ and\\ elevated\\ alpha\\ fetoprotein\\ level\\ in\\ an\\ infant\\ with\\ isolated\\ hemihyperplasia\\.\\ j\\ pediatr\\ hematol\\ oncol\\,\\ 2008\\.\\ 30\\(10\\)\\:\\ p\\.\\ 775\\-7\\.\ \(0\)\
\-\ 5\\.\\	lee\\,\\ i\\.j\\.\\,\\ et\\ al\\.\\,\\ radiological\\ findings\\ in\\ a\\ case\\ of\\ multiple\\ focal\\ nodular\\ hyperplasia\\ associated\\ with\\ portal\\ vein\\ atresia\\ and\\ portopulmonary\\ hypertension\\.\\ korean\\ j\\ radiol\\,\\ 2008\\.\\ 9\\(4\\)\\:\\ p\\.\\ 386\\-9\\.\ \(0\)\
\-\ 6\\.\\	gutweiler\\,\\ j\\.r\\.\\,\\ et\\ al\\.\\,\\ hepatoblastoma\\ presenting\\ with\\ focal\\ nodular\\ hyperplasia\\ after\\ treatment\\ of\\ neuroblastoma\\.\\ j\\ pediatr\\ surg\\,\\ 2008\\.\\ 43\\(12\\)\\:\\ p\\.\\ 2297\\-300\\.\ \(0\)\
\-\ 7\\.\\	wasif\\,\\ n\\.\\,\\ et\\ al\\.\\,\\ focal\\ nodular\\ hyperplasia\\:\\ report\\ of\\ an\\ unusual\\ case\\ and\\ review\\ of\\ the\\ literature\\.\\ am\\ surg\\,\\ 2008\\.\\ 74\\(11\\)\\:\\ p\\.\\ 1100\\-3\\.\ \(0\)\
\-\ 8\\.\\	portmann\\,\\ b\\.\\,\\ et\\ al\\.\\,\\ nodular\\ transformation\\ of\\ the\\ liver\\ associated\\ with\\ portal\\ and\\ pulmonary\\ arterial\\ hypertension\\.\\ gastroenterology\\,\\ 1993\\.\\ 104\\(2\\)\\:\\ p\\.\\ 616\\-21\\.\ \(0\)\
\-\ 9\\.\\	wang\\,\\ h\\.l\\.\\,\\ et\\ al\\.\\,\\ glypican\\-3\\ as\\ a\\ useful\\ diagnostic\\ marker\\ that\\ distinguishes\\ hepatocellular\\ carcinoma\\ from\\ benign\\ hepatocellular\\ mass\\ lesions\\.\\ arch\\ pathol\\ lab\\ med\\,\\ 2008\\.\\ 132\\(11\\)\\:\\ p\\.\\ 1723\\-8\\.\ \(0\)\
\-\ 10\\.\\	iyer\\,\\ a\\.\\,\\ et\\ al\\.\\,\\ different\\ cytokeratin\\ and\\ neuronal\\ cell\\ adhesion\\ molecule\\ staining\\ patterns\\ in\\ focal\\ nodular\\ hyperplasia\\ and\\ hepatic\\ adenoma\\ and\\ their\\ significance\\.\\ hum\\ pathol\\,\\ 2008\\.\\ 39\\(9\\)\\:\\ p\\.\\ 1370\\-7\\.\ \(0\)\
\-\ 9\\.\\	stocker\\,\\ j\\.t\\.\\ and\\ k\\.g\\.\\ ishak\\,\\ focal\\ nodular\\ hyperplasia\\ of\\ the\\ liver\\:\\ a\\ study\\ of\\ 21\\ pediatric\\ cases\\.\\ cancer\\,\\ 1981\\.\\ 48\\(2\\)\\:\\ p\\.\\ 336\\-45\\.\ \(0\)\
\-\ 10\\.\\	erdogan\\,\\ d\\.\\,\\ et\\ al\\.\\,\\ morbidity\\ and\\ mortality\\ after\\ liver\\ resection\\ for\\ benign\\ and\\ malignant\\ hepatobiliary\\ lesions\\.\\ liver\\ int\\,\\ 2009\\.\\ 29\\(2\\)\\:\\ p\\.\\ 175\\-80\\.\ \(0\)\
\-\ 11\\.\\	bonney\\,\\ g\\.k\\.\\,\\ et\\ al\\.\\,\\ indication\\ for\\ treatment\\ and\\ long\\-term\\ outcome\\ of\\ focal\\ nodular\\ hyperplasia\\.\\ hpb\\ \\(oxford\\)\\,\\ 2007\\.\\ 9\\(5\\)\\:\\ p\\.\\ 368\\-372\\.\ \(0\)\
\-\ 12\\.\\	bahirwani\\,\\ r\\.\\ and\\ k\\.r\\.\\ reddy\\,\\ review\\ article\\:\\ the\\ evaluation\\ of\\ solitary\\ liver\\ masses\\.\\ aliment\\ pharmacol\\ ther\\,\\ 2008\\.\\ 28\\(8\\)\\:\\ p\\.\\ 953\\-65\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ al\\.\\:\\ 0\\.09567835336079823\ \(0\)\
\-\ p\\:\\ 0\\.08013814980642896\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.05496538169684603\ \(0\)\
\-\ et\\:\\ 0\\.05478953154238561\ \(0\)\
\-\ nodular\\:\\ 0\\.05147324788280813\ \(0\)\
\-\ liver\\:\\ 0\\.04615490617492517\ \(0\)\
\-\ 2008\\:\\ 0\\.045183057299491194\ \(0\)\
\-\ arrows\\:\\ 0\\.04031632568114386\ \(0\)\
\-\ \\:\\:\\ 0\\.033937755571521275\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.03225306054491509\ \(0\)\
\-\ focal\\:\\ 0\\.03186022981903919\ \(0\)\
\-\ yellow\\:\\ 0\\.02882340239144736\ \(0\)\
\-\ fig\\:\\ 0\\.02761962349530202\ \(0\)\
\-\ pathol\\:\\ 0\\.025920210887585945\ \(0\)\
\-\ scar\\:\\ 0\\.023283601030166613\ \(0\)\
\-\ \\,\\:\\ 0\\.021204443774200058\ \(0\)\
\-\ \\(\\:\\ 0\\.020746681432591296\ \(0\)\
\-\ \\)\\:\\ 0\\.02049324964294088\ \(0\)\
\-\ j\\:\\ 0\\.020155046299557375\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.019283413025545187\ \(0\)\
\-\ carcinoma\\:\\ 0\\.018970712819967622\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.018361817384809683\ \(0\)\
\-\ red\\:\\ 0\\.017462700772624958\ \(0\)\
\-\ 2\\:\\ 0\\.016815576338869223\ \(0\)\
\-\ int\\:\\ 0\\.016756196217149157\ \(0\)\
\-\ fnh\\:\\ 0\\.01652901246521801\ \(0\)\
\-\ arrow\\:\\ 0\\.016320023672336714\ \(0\)\
\-\ pediatr\\:\\ 0\\.016126530272457546\ \(0\)\
\-\ review\\:\\ 0\\.014504689173407134\ \(0\)\
\-\ 2009\\:\\ 0\\.014225124266266381\ \(0\)\
\-\ hepatic\\:\\ 0\\.013975826443104486\ \(0\)\
\-\ image\\:\\ 0\\.013938324628185905\ \(0\)\
\-\ 9\\:\\ 0\\.013834130660163875\ \(0\)\
\-\ 10\\.\\:\\ 0\\.01380981174765101\ \(0\)\
\-\ surg\\:\\ 0\\.013321008765697626\ \(0\)\
\-\ 9\\.\\:\\ 0\\.013077952830799423\ \(0\)\
\-\ literature\\:\\ 0\\.012000027986397889\ \(0\)\
\-\ portal\\:\\ 0\\.011744204465875166\ \(0\)\
\-\ choliangiocarcinoma\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ quiz\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ titelbaum\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ d\\.s\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ mclarney\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ j\\.k\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 453\\-71\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ wheeler\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ y\\.y\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 190\\-3\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ demir\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ h\\.a\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ hemihyperplasia\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 775\\-7\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ i\\.j\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ portopulmonary\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 386\\-9\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ gutweiler\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 2297\\-300\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ wasif\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 1100\\-3\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ portmann\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 616\\-21\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ h\\.l\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ glypican\\-3\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 1723\\-8\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ iyer\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 1370\\-7\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ stocker\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ j\\.t\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ k\\.g\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ ishak\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 336\\-45\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ erdogan\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 175\\-80\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ bonney\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ g\\.k\\.\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ hpb\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ oxford\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 368\\-372\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ bahirwani\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ k\\.r\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ aliment\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ 953\\-65\\:\\ 0\\.011508509691862269\ \(0\)\
\-\ mass\\:\\ 0\\.010860609724063906\ \(0\)\
\-\ lighter\\:\\ 0\\.01060361781123571\ \(0\)\
\-\ hematol\\:\\ 0\\.01060361781123571\ \(0\)\
\-\ j\\.r\\.\\:\\ 0\\.01060361781123571\ \(0\)\
\-\ hum\\:\\ 0\\.01060361781123571\ \(0\)\
\-\ hypointense\\:\\ 0\\.010583144880336142\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.010228553208850442\ \(0\)\
\-\ 11\\:\\ 0\\.010209513434799136\ \(0\)\
\-\ molecule\\:\\ 0\\.010074289993862126\ \(0\)\
\-\ reddy\\:\\ 0\\.010074289993862126\ \(0\)\
\-\ pharmacol\\:\\ 0\\.010074289993862126\ \(0\)\
\-\ report\\:\\ 0\\.009987169287696506\ \(0\)\
\-\ case\\:\\ 0\\.009762425236904808\ \(0\)\
\-\ exp\\:\\ 0\\.009698725930609149\ \(0\)\
\-\ distinguishes\\:\\ 0\\.009698725930609149\ \(0\)\
\-\ adhesion\\:\\ 0\\.009698725930609149\ \(0\)\
\-\ tan\\:\\ 0\\.009407415811399998\ \(0\)\
\-\ 167\\:\\ 0\\.009407415811399998\ \(0\)\
\-\ korean\\:\\ 0\\.009407415811399998\ \(0\)\
\-\ 132\\:\\ 0\\.009407415811399998\ \(0\)\
\-\ adenoma\\:\\ 0\\.009317217628736324\ \(0\)\
\-\ coronal\\:\\ 0\\.009289877420205527\ \(0\)\
\-\ hyperintense\\:\\ 0\\.009262820534995221\ \(0\)\
\-\ 1981\\:\\ 0\\.009169398113235566\ \(0\)\
\-\ hepatobiliary\\:\\ 0\\.009169398113235566\ \(0\)\
\-\ delayed\\:\\ 0\\.00908088862732423\ \(0\)\
\-\ slightly\\:\\ 0\\.009018867515031522\ \(0\)\
\-\ pitfalls\\:\\ 0\\.008968157016855332\ \(0\)\
\-\ 25\\-30\\:\\ 0\\.008968157016855332\ \(0\)\
\-\ radiologic\\-pathologic\\:\\ 0\\.008968157016855332\ \(0\)\
\-\ fetoprotein\\:\\ 0\\.008968157016855332\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.008968157016855332\ \(0\)\
\-\ hypertension\\:\\ 0\\.008795772982507019\ \(0\)\
\-\ differentiates\\:\\ 0\\.008793834049982588\ \(0\)\
\-\ wang\\:\\ 0\\.008793834049982588\ \(0\)\
\-\ ther\\:\\ 0\\.008793834049982588\ \(0\)\
\-\ oncol\\:\\ 0\\.008640070295861982\ \(0\)\
\-\ n\\.\\:\\ 0\\.008640070295861982\ \(0\)\
\-\ note\\:\\ 0\\.008611137147524258\ \(0\)\
\-\ hepatoblastoma\\:\\ 0\\.008502523930773437\ \(0\)\
\-\ gastroenterology\\:\\ 0\\.008502523930773437\ \(0\)\
\-\ 1988\\:\\ 0\\.008378098108574579\ \(0\)\
\-\ nonoperative\\:\\ 0\\.008160011836168357\ \(0\)\
\-\ lee\\:\\ 0\\.008160011836168357\ \(0\)\
\-\ article\\:\\ 0\\.008063265136228773\ \(0\)\
\-\ radiol\\:\\ 0\\.007888942169356027\ \(0\)\
\-\ 104\\:\\ 0\\.007888942169356027\ \(0\)\
\-\ neuronal\\:\\ 0\\.007888942169356027\ \(0\)\
\-\ demarcated\\:\\ 0\\.007735178415235423\ \(0\)\
\-\ benign\\:\\ 0\\.007699870410008359\ \(0\)\
\-\ 1993\\:\\ 0\\.007664594575456995\ \(0\)\
\-\ alpha\\:\\ 0\\.007473206227948019\ \(0\)\
\-\ 12\\.\\:\\ 0\\.007473206227948019\ \(0\)\
\-\ staining\\:\\ 0\\.0074151752063150765\ \(0\)\
\-\ hcc\\:\\ 0\\.0073596143519824445\ \(0\)\
\-\ situ\\:\\ 0\\.007255119955541796\ \(0\)\
\-\ marker\\:\\ 0\\.007255119955541796\ \(0\)\
\-\ r\\.\\:\\ 0\\.00720585059786184\ \(0\)\
\-\ patterns\\:\\ 0\\.0071125621331331905\ \(0\)\
\-\ significance\\:\\ 0\\.0071125621331331905\ \(0\)\
\-\ mr\\:\\ 0\\.007089293660434553\ \(0\)\
\-\ branching\\:\\ 0\\.007068304232773293\ \(0\)\
\-\ indication\\:\\ 0\\.007068304232773293\ \(0\)\
\-\ adjacent\\:\\ 0\\.007054402726199131\ \(0\)\
\-\ excised\\:\\ 0\\.007025497675563123\ \(0\)\
\-\ 11\\.\\:\\ 0\\.006943878410574435\ \(0\)\
\-\ recovered\\:\\ 0\\.006904905873825505\ \(0\)\
\-\ interface\\:\\ 0\\.006904905873825505\ \(0\)\
\-\ morbidity\\:\\ 0\\.006794517638801924\ \(0\)\
\-\ outcome\\:\\ 0\\.006660504382848813\ \(0\)\
\-\ whereas\\:\\ 0\\.006629045438228629\ \(0\)\
\-\ b\\.\\:\\ 0\\.006629045438228629\ \(0\)\
\-\ d\\.\\:\\ 0\\.006629045438228629\ \(0\)\
\-\ clin\\:\\ 0\\.0065683143473214585\ \(0\)\
\-\ fairly\\:\\ 0\\.006538976415399711\ \(0\)\
\-\ radiographics\\:\\ 0\\.006538976415399711\ \(0\)\
\-\ radiological\\:\\ 0\\.006454722471355884\ \(0\)\
\-\ curvilinear\\:\\ 0\\.0064278043418483964\ \(0\)\
\-\ med\\:\\ 0\\.006401430050311165\ \(0\)\
\-\ voids\\:\\ 0\\.006375578056451922\ \(0\)\
\-\ 74\\:\\ 0\\.006375578056451922\ \(0\)\
\-\ 1999\\:\\ 0\\.006325360979653234\ \(0\)\
\-\ transformation\\:\\ 0\\.006325360979653234\ \(0\)\
\-\ 2007\\:\\ 0\\.00630095871723528\ \(0\)\
\-\ a\\.\\:\\ 0\\.006253481374975651\ \(0\)\
\-\ 8\\.\\:\\ 0\\.006230374877456851\ \(0\)\
\-\ 4\\:\\ 0\\.006216636828143721\ \(0\)\
\-\ long\\-term\\:\\ 0\\.006163412352146734\ \(0\)\
\-\ correlation\\:\\ 0\\.006141833628972829\ \(0\)\
\-\ atresia\\:\\ 0\\.006141833628972829\ \(0\)\
\-\ shows\\:\\ 0\\.006134134986237281\ \(0\)\
\-\ dark\\:\\ 0\\.006099717620855046\ \(0\)\
\-\ mortality\\:\\ 0\\.006079158408102906\ \(0\)\
\-\ cell\\:\\ 0\\.006026738150343307\ \(0\)\
\-\ 43\\:\\ 0\\.006019354836260486\ \(0\)\
\-\ lesions\\:\\ 0\\.005972742836407174\ \(0\)\
\-\ 7\\.\\:\\ 0\\.005943653455515905\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.005907387706028861\ \(0\)\
\-\ is\\:\\ 0\\.005872488547098962\ \(0\)\
\-\ \\]\\:\\ 0\\.005837745433567643\ \(0\)\
\-\ \\[\\:\\ 0\\.005820900257541653\ \(0\)\
\-\ useful\\:\\ 0\\.005820900257541653\ \(0\)\
\-\ 29\\:\\ 0\\.005820900257541653\ \(0\)\
\-\ isolated\\:\\ 0\\.005804269675586784\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.0057397882717622715\ \(0\)\
\-\ am\\:\\ 0\\.0057397882717622715\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.005648671089078797\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.005577315459133805\ \(0\)\
\-\ solitary\\:\\ 0\\.005536302148124172\ \(0\)\
\-\ resected\\:\\ 0\\.0055229124612218355\ \(0\)\
\-\ different\\:\\ 0\\.0055229124612218355\ \(0\)\
\-\ isointense\\:\\ 0\\.005483548181625638\ \(0\)\
\-\ lab\\:\\ 0\\.005457949655008959\ \(0\)\
\-\ 48\\:\\ 0\\.005457949655008959\ \(0\)\
\-\ color\\:\\ 0\\.005445336194288676\ \(0\)\
\-\ 6\\.\\:\\ 0\\.005420469099026673\ \(0\)\
\-\ unusual\\:\\ 0\\.005396066836608719\ \(0\)\
\-\ pediatric\\:\\ 0\\.005372112347485747\ \(0\)\
\-\ 1\\:\\ 0\\.005308946130443099\ \(0\)\
\-\ homogeneous\\:\\ 0\\.005280461879243908\ \(0\)\
\-\ infant\\:\\ 0\\.005280461879243908\ \(0\)\
\-\ associated\\:\\ 0\\.005264915305242042\ \(0\)\
\-\ 28\\:\\ 0\\.005258520471520173\ \(0\)\
\-\ ordered\\:\\ 0\\.005247686525286889\ \(0\)\
\-\ phase\\:\\ 0\\.005247686525286889\ \(0\)\
\-\ margin\\:\\ 0\\.005247686525286889\ \(0\)\
\-\ form\\:\\ 0\\.005215713914310002\ \(0\)\
\-\ 39\\:\\ 0\\.00518450566254296\ \(0\)\
\-\ cavernous\\:\\ 0\\.005174266527476346\ \(0\)\
\-\ 19\\:\\ 0\\.005144022324758938\ \(0\)\
\-\ 21\\:\\ 0\\.005047987641760222\ \(0\)\
\-\ arch\\:\\ 0\\.005020502773355741\ \(0\)\
\-\ hemangioma\\:\\ 0\\.0049847338775488035\ \(0\)\
\-\ even\\:\\ 0\\.004967210352311021\ \(0\)\
\-\ from\\:\\ 0\\.004959930991465583\ \(0\)\
\-\ arterial\\:\\ 0\\.004882956408267195\ \(0\)\
\-\ their\\:\\ 0\\.004882956408267195\ \(0\)\
\-\ the\\:\\ 0\\.00487301656266044\ \(0\)\
\-\ recurrence\\:\\ 0\\.004866739019235136\ \(0\)\
\-\ near\\:\\ 0\\.004827055628655017\ \(0\)\
\-\ 5\\.\\:\\ 0\\.0048115139804744455\ \(0\)\
\-\ parenchyma\\:\\ 0\\.0047511340618703254\ \(0\)\
\-\ radiology\\:\\ 0\\.00471476728053486\ \(0\)\
\-\ a\\:\\ 0\\.004659788794213331\ \(0\)\
\-\ references\\:\\ 0\\.004638156964832393\ \(0\)\
\-\ after\\:\\ 0\\.0046161911295279435\ \(0\)\
\-\ 12\\:\\ 0\\.004565794295198802\ \(0\)\
\-\ presenting\\:\\ 0\\.00454673581031479\ \(0\)\
\-\ treatment\\:\\ 0\\.004515971173892655\ \(0\)\
\-\ fibrous\\:\\ 0\\.004509433757515761\ \(0\)\
\-\ vessels\\:\\ 0\\.004491174955982158\ \(0\)\
\-\ sagittal\\:\\ 0\\.004449538710843837\ \(0\)\
\-\ diagnostic\\:\\ 0\\.00442059111620373\ \(0\)\
\-\ 4\\.\\:\\ 0\\.004392271501828718\ \(0\)\
\-\ structures\\:\\ 0\\.00429512465383122\ \(0\)\
\-\ 30\\:\\ 0\\.004289933859601925\ \(0\)\
\-\ 8\\:\\ 0\\.004171171747061812\ \(0\)\
\-\ which\\:\\ 0\\.004164868374001433\ \(0\)\
\-\ vein\\:\\ 0\\.0040364664778252185\ \(0\)\
\-\ malignant\\:\\ 0\\.004032207149320236\ \(0\)\
\-\ and\\:\\ 0\\.0039949779340048485\ \(0\)\
\-\ obtained\\:\\ 0\\.003965882638046791\ \(0\)\
\-\ girl\\:\\ 0\\.003922163748028457\ \(0\)\
\-\ was\\:\\ 0\\.0038705385987481203\ \(0\)\
\-\ 3\\.\\:\\ 0\\.003817068162063613\ \(0\)\
\-\ now\\:\\ 0\\.0038134668272867462\ \(0\)\
\-\ elevated\\:\\ 0\\.0037850083046462963\ \(0\)\
\-\ masses\\:\\ 0\\.00377100835247531\ \(0\)\
\-\ 10\\:\\ 0\\.0037606060422283425\ \(0\)\
\-\ cases\\:\\ 0\\.003716463268904873\ \(0\)\
\-\ flow\\:\\ 0\\.0036867544084314835\ \(0\)\
\-\ central\\:\\ 0\\.0036705370193994245\ \(0\)\
\-\ study\\:\\ 0\\.0036705370193994245\ \(0\)\
\-\ surrounding\\:\\ 0\\.0036673175774996937\ \(0\)\
\-\ cancer\\:\\ 0\\.0036673175774996937\ \(0\)\
\-\ 2\\.\\:\\ 0\\.003547577208616525\ \(0\)\
\-\ between\\:\\ 0\\.0035358949559063236\ \(0\)\
\-\ \\.\\:\\ 0\\.0035221471845931027\ \(0\)\
\-\ post\\:\\ 0\\.0035128394687627853\ \(0\)\
\-\ enhancing\\:\\ 0\\.003498633854940939\ \(0\)\
\-\ 1\\.\\:\\ 0\\.003484581157046476\ \(0\)\
\-\ resection\\:\\ 0\\.0034790021612535493\ \(0\)\
\-\ diffuse\\:\\ 0\\.003377294282474301\ \(0\)\
\-\ renal\\:\\ 0\\.003351795756472675\ \(0\)\
\-\ 6\\:\\ 0\\.0033317495579306454\ \(0\)\
\-\ see\\:\\ 0\\.0033292652888104284\ \(0\)\
\-\ in\\:\\ 0\\.0033007615937878975\ \(0\)\
\-\ 5\\:\\ 0\\.0032639170005798477\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0032592040603395085\ \(0\)\
\-\ evaluation\\:\\ 0\\.003240520621183822\ \(0\)\
\-\ level\\:\\ 0\\.003215259827215316\ \(0\)\
\-\ an\\:\\ 0\\.003085286851918355\ \(0\)\
\-\ enhancement\\:\\ 0\\.002990194211648872\ \(0\)\
\-\ than\\:\\ 0\\.0029230402805721593\ \(0\)\
\-\ these\\:\\ 0\\.00290319150386141\ \(0\)\
\-\ for\\:\\ 0\\.0028555149424649416\ \(0\)\
\-\ metastatic\\:\\ 0\\.0028082368193421544\ \(0\)\
\-\ abdominal\\:\\ 0\\.0027884063160863123\ \(0\)\
\-\ without\\:\\ 0\\.002626649042243029\ \(0\)\
\-\ 3\\:\\ 0\\.0026122395910007047\ \(0\)\
\-\ tumor\\:\\ 0\\.002600825459021947\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0025616440349613837\ \(0\)\
\-\ well\\:\\ 0\\.00252360437724367\ \(0\)\
\-\ this\\:\\ 0\\.002509496640506875\ \(0\)\
\-\ contrast\\:\\ 0\\.002497096196877161\ \(0\)\
\-\ large\\:\\ 0\\.002439350433199843\ \(0\)\
\-\ \\-\\:\\ 0\\.00239129041606836\ \(0\)\
\-\ but\\:\\ 0\\.002379247129286603\ \(0\)\
\-\ findings\\:\\ 0\\.0023744607516840203\ \(0\)\
\-\ multiple\\:\\ 0\\.0023496161925316826\ \(0\)\
\-\ presents\\:\\ 0\\.0022789090019685715\ \(0\)\
\-\ also\\:\\ 0\\.0021992422893866207\ \(0\)\
\-\ within\\:\\ 0\\.0021281088882324824\ \(0\)\
\-\ of\\:\\ 0\\.0019772185514018927\ \(0\)\
\-\ that\\:\\ 0\\.0019268677918522499\ \(0\)\
\-\ on\\:\\ 0\\.0018900548625729193\ \(0\)\
\-\ as\\:\\ 0\\.0016874379972508196\ \(0\)\
\-\ to\\:\\ 0\\.001672590503040416\ \(0\)\
\-\ ct\\:\\ 0\\.0015604486336710742\ \(0\)\
\-\ are\\:\\ 0\\.0015207230711874696\ \(0\)\
\-\ pain\\:\\ 0\\.0013624127513456067\ \(0\)\
\-\ year\\:\\ 0\\.0012481792027061551\ \(0\)\
\-\ old\\:\\ 0\\.0011422122674441967\ \(0\)\
\-\ patient\\:\\ 0\\.0011182662283503759\ \(0\)\
\-\ with\\:\\ 0\\.0007637348308739538\ \(0\)\
